Stagnant in cardiovascular prevention: Alarming trends and persistent socioeconomic obstacles;Prevención cardiovascular estancada: tendencias alarmantes y barreras socioeconómicas persistentes

Revista Espanola de Cardiologia

Volumn 63, Issue 11, 2010, Pages 1340-1348

  Romero, Tomás ^a,b   Romero, Camila X ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Departamento de Medicina   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Built environment; Cardiovascular risk; Prevention; Socioeconomic factors

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; DISEASE CONTROL; GENETIC PREDISPOSITION; HUMAN; ISCHEMIC HEART DISEASE; OBESITY; PREVENTIVE MEDICINE; SOCIAL STATUS;

EID: 79751515266     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70303-1     Document Type: Article

References (56)

1. A. Kagan, W.B. Kannel, T.R. Dawber, and N. Revotskie The coronary profile Ann N Y Acad Sci 97 1963 883 894
2. A. Keys, C. Aravanis, H.W. Blackburn, F.SP. Van Buchem, R. Buzina, and B.S. Djordjevic Epidemiologic studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries Acta Med Scand 460 1967 1 392
3. W.B. Kannel, and T.J. Thom Declining cardiovascular mortality Circulation 70 1984 331 336
4. P. Puska Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland Public Health Med 4 2002 5 7 (Pubitemid 35154502)
5. M. O'Flaherty, J. Bishop, A. Redpath, T. McLaughlin, D. Murphy, and J. Chalmers Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study BMJ 339 2009 b2613
6. F. Levi, F. Lucchini, E. Negri, and C. La Vecchia Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world Heart 88 2002 119 124 (Pubitemid 34787755)
7. J. Muller-Nordhorn, S. Binting, S. Roll, and S.N. Willich An update on regional variation in cardiovascular mortality within Europe Eur Heart J 29 2008 1316 1326 (Pubitemid 351768126)
8. E.S. Ford, and S. Capewell Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates J Am Coll Cardiol 50 2007 2128 2132 (Pubitemid 350117339)
9. T. Rodríguez, M. Malvezzi, L. Chatenoud, C. Bosetti, F. Levi, and E. Negri Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000 Heart 92 2006 453 460
10. D.S. Lee, M. Chiu, D.G. Manuel, K. Tu, X. Wang, and P.C. Austin Canadian Cardiovascular Outcomes Research Team: Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors CMAJ 181 2009 E55 66
11. I. Hajjar, and T. Kotchen Trends in prevalence, awareness and treatment and control of hypertension in the United States, 1988-2000 JAMA 290 2003 199 206 (Pubitemid 37430058)
12. M.A. Sánchez-Chaparro, J. Román García, E. Calvo-Bonacho, T. Gómez-Larios, A. Fernández-Meseguer, and J.C. Sáinz-Gutiérrez Prevalencia de factores de riesgo cardiovascular en la población laboral española Rev Esp Cardiol 59 2006 421 430
13. Centers for Disease Control and Prevention. National Health and Nutrition. Examination Survey 2003-2006. Disponible en: http://www.cdc.gov/nchs/ nhanes.htm
14. J. Kain, F. Vio, and C. Albala Obesity trends and determinant factors in Latin America Cad Saúde Pública 19 Supl 1 2003 S77 86
15. Centers for Disease Control and Prevention. Department of Health and Human Services Percentage of Civilian, Noninstitutionalized Population with Diagnosed Diabetes, by Age, United States, 1980-2006. Disponible en: http://www.cdc.gov/Diabetes/statistics/prev/national/figbyage.htm
16. World Health Organization. World Health Organization 2008 Report. Global Strategy on Diet, Physical Activity and Health. Obesity and Overweight. Disponible en: http://www.who.int/dietphysicalactivity/media/en/gsfs-obesity.pdf
17. S.P. Fortmann, E. Ford, M.H. Criqui, A.R. Folsom, T.B. Harris, Y. Hong CDC/AHA Wokshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Population Science Discussion Group Circulation 110 2004 e554 e559
18. W.S. Weintraub, and G.A. Diamond Predicting cardiovascular events with coronary calcium score N Engl J Med 358 2008 1394 1396 (Pubitemid 351468419)
19. H.H. Hobbs, D.W. Russell, M.S. Brown, and J.L. Goldstein The LDL receptor locus infamilial hypercholesterolemia: mutational analysis of a membrane protein Annu Rev Genet 24 1990 133 170 (Pubitemid 120011544)
20. Qing Wang Molecular genetics of coronary artery disease Curr Opin Cardiol 20 2005 182 188 (Pubitemid 40704874)
21. Kristiansson K. Genetics of Cardiovascular Disease: a Candidate Gene Study of USFI. Publications of the National Public Health Institute, A8/2008. Disponible en: http://www.ktl.fi/attachments/suomi/julkaisut/julkaisusarja-a/ 2008/2008a08.pdf
22. V.J. Dzau, E.M. Antman, H.R. Black, D.L. Hayes, and J.E. Manson The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: Part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease) Circulation 114 2006 2850 2870 (Pubitemid 46018288)
23. G. Rose Sick individuals and sick populations Int J Epidemiol 14 1985 32 38 (Pubitemid 15109489)
24. L. Goldman, and E.F. Cook The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle Ann Intern Med 101 1984 825 836 (Pubitemid 15187377)
25. E.S. Ford, U.A. Ajani, J.B. Croft, J.A. Critchley, D.R. Labarthe, and T.E. Kottke Explaining the decrease in US from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398 (Pubitemid 46883773)
26. N. Urban Cost effectiveness I.S. Ockene, J.K. Ockene, Prevention of coronary heart disease 1992 Little, Brown & Co. Boston, Toronto, London 555 566
27. B.G. Link, and J.C. Phelan McKweon and the idea that social conditions are fundamental causes of disease Am J Public Health 92 2002 730 732 (Pubitemid 34441620)
28. M. Marmot Social determinants of health inequalities Lancet 365 2005 1099 1104 (Pubitemid 40386787)
29. J. Colgrove The McKweon thesis: a historical controversy and its enduring influence Am J Public Health 92 2002 725 729 (Pubitemid 34441619)
30. A. Diez-Roux Persistent social patterning of cardiovascular risk: rethinking the familiar Circulation 111 2005 3020 3021
31. G.S. Lovasi, M.A. Hutson, M. Guerra, and K.M. Neckerman Built environments and obesity in disadvantaged populations Epidemiol Rev 31 2009 7 20
32. F. Li, P. Harmer, B.J. Cardinal, and N. Vongjaturapat Built environment and changes in blood pressure in middle aged and older adults Prev Med 48 2009 237 241
33. A.S. Hosler Retail food availability, obesity and cigarette smoking in rural communities J Rural Health 25 2009 203 210
34. K. Jamerson, G.l. Bakris, B. Dahlöf, B. Pitt, E. Velazquez, and J. Gupte Exceptional early blood pressure control rates: the ACCOMPLISH trial Blood Press 16 2007 80 86 (Pubitemid 47050368)
35. J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, and P.W. Macfarlane Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1310
36. T. Romero Cardiac rehabilitation as a first step in secondary prevention Rev Med Chile 128 2000 787 798
37. P.A. Ades Cardiac rehabilitation and secondary prevention of coronary artery disease N Engl J Med 345 2001 892 902
38. G.C. Fonarow, A. Gawlinski, S. Moughrabi, and J.H. Tillisch Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) Am J Cardiol 87 2001 819 822 (Pubitemid 32244197)
39. P. Sever, B. Dahlof, N. Poulter, H. Wedel, G. Beevers, and M. Caulfield Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial Eur Heart J 27 2006 2882 2988
40. S.E. Nissen, J.C. Tardif, S.J. Nicholls, J.H. Revkin, C.L. Shear, and W.T. Duggan Effects of torcetrapib on the progression of coronary atherosclerosis N Engl J Med 356 2007 1304 1316 (Pubitemid 46513296)
41. Action to Control Cardiovascular Risk in Diabetes Study Group H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr, and J.T. Bigger Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
42. I. Hjermann, B.K. Velve, I. Holme, and P. Leren Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo study group of a randomised trial in healthy men Lancet 2 1981 1303 1310 (Pubitemid 12180386)
43. E. Koch, T. Romero, C. Akel, C. Diaz, L. Manriquez, M. Paredes, and A. Taylor Impact of cardiovascular risk factors on the relationship between education and mortality. A Chilean prospective cohort study: the San Francisco Project [abstract #0188] Circulation 118 2008 e452
44. E.B. Loucks, L.M. Sullivan, L.J. Hayes, R.B. D'Agostino, M.G. Larson, and R.S. Vasan Association of educational level with inflammatory markers in the Framingham Offspring Study Am J Epidemiol 163 2006 622 628
45. M.A. Albert, R.J. Glynn, J. Buring, and P.M. Ridker Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events Circulation 114 2006 2619 2626 (Pubitemid 44967345)
46. J. Nijm, M. Kristenson, A.G. Olsson, and L. Jonasson Impaired cortisol response to acute stressors in patients with coronary disease. Implications or inflammatory activity J Intern Med 262 2007 375 384 (Pubitemid 47246971)
47. N. Ranjit, A.V. Diez-Roux, S. Shea, M. Cushman, H. Ni, and T. Seeman Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis Circulation 116 2007 2383 2390 (Pubitemid 350145073)
48. H. Hemingway, M. Shipley, M.J. Mullen, M. Kumari, E. Brunner, and M. Taylor Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study) Am J Cardiol 92 2003 984 987 (Pubitemid 37214817)
49. T. Romero Modifiable cardiovascular risk factors: which are we really modifying? Rev Med Chile 137 2009 1503 1506
50. P. López-Jaramillo Enfermedades cardiometabólicas en Iberoamérica: papel de la programación fetal en respuesta a la desnutrición materna Rev Esp Cardiol 62 2009 670 676
51. E. Koch, T. Romero, C. Romero, H. Aguilera, M. Paredes, and M. Vargas Early life and adult socioeconomic influences on mortality risk: preliminary report of a'pauper rich' paradox in a Chilean adult cohort Ann Epidemiol 20 2010 487 492
52. E. Koch, T. Romero, C.X. Romero, C. Akel, L. Manriquez, and M. Paredes Impact of education, income and chronic disease factors on mortality of adults: does a "pauper-rich" paradox exist in Latin America societies? Public Health 124 2010 39 48
53. C. Albala, F. Vio, F. Kain, and R. Uauy Nutrition transition in Chile: determinants and consequences Public Health Nutr 5 2002 123 128 (Pubitemid 41128298)
54. H. Seligman, and D. Schillinger Hunger and socioeconomic disparities in chronic disease N Engl J Med 363 2010 6 9
55. o 96
56. K. Teo, C.K. Chow, M. Vaz, S. Rangarajan, S. Yusuf PURE Investigators-Writing Group The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries Am Heart J 158 2009 1 7.e1